Skip to content

Sabing Lee

 | 

Sabing H. Lee’s practice includes strategic patent procurement, patent portfolio management, intellectual property due diligence and general counseling on infringement, licensing, international IP protection and post-grant proceedings. Sabing currently represents clients in a wide range of technologies, with an emphasis on medical devices and procedures and materials science.

Sabing co-chairs the firm’s Medical Devices and Procedures group. In the medical device field, he has worked extensively with cardiovascular, orthopedic, wound care and healthcare AI technologies. Sabing has guided the IP strategies for investments and acquisitions valued in excess of $5 billion dollars, including ev3 (acquired by Covidien), CardiAQ Valve Technologies (acquired by Edwards Lifesciences), Tornier/Wright Medical (acquired by Stryker), CathWorks (acquisition option agreement with Medtronic), AVITA Medical (debt financing with OrbiMed), HealthpointCapital (acquisition of SteriCUBE), and Paragonix Technologies (acquisition by Getinge).

Sabing currently serves on the Board of Directors for Octane, an organization that drives technology industry growth and innovation in Orange County by connecting ideas and people with resources and capital.

Sabing has been recognized among the Top Intellectual Property Lawyers in California by Daily Journal for 2025, and was cited for outstanding work in patent law in the 2024 edition of the Intellectual Asset Management (IAM) “Patent 1000 Guide” for Prosecution. In addition, he has been named a Patent Star in Managing IP’s “IP STARS” guide for his outstanding intellectual property legal work in 2018-2024. He has received “Star” recognition in the “Life Sciences Survey” published by Legal Media Group (LMG) Life Sciences from 2012-2019 and 2022-2024. He was noted as being among the top patent strategists in the country for his patent prosecution, patent advisory, strategy and management practice. Sabing was selected for inclusion in the “Southern California Super Lawyers” list for his work in intellectual property law from 2013-2018 by Super Lawyers magazine, and was named to the Daily Journal’s list of the “Top Intellectual Property Attorneys of 2014”, where he was recognized among the Top 25 Portfolio Managers & Patent Prosecutors of Intellectual Property.

Sabing joined the firm in 1997 and became a partner in 2003.
University of California – Berkeley – School of Law, J.D.
University of California – Los Angeles (UCLA), M.S., Materials Science & Engineering
University of California – Los Angeles (UCLA), B.S., Materials Engineering, Phi Beta Kappa, Tau Beta Pi Engineering Honor Society
State Bar of California
U.S. Patent and Trademark Office
Biotech

Synthetic Biology & Nanotechnology

Consumer Products & Services

Aesthetics & Personal Care Products

Energy

Clean Technology

Medical Devices & Procedures

Advertising, Media & Entertainment Practice
Brand Portfolio Management
Copyright
Covered Business Method (CBM)
Data Privacy
Design Patents
Due Diligence
Global Portfolio Management
Inter Partes Review (IPR)
IP Strategy
IP Transactions, Agreements & Venture Capital
Litigation
Opinions & Counseling
Patent Strategy & Prosecution
Patent Trial & Appeal Board (PTAB) Trials (Post Grant)
Post-Grant Review (PGR)
Trademark & Brand Protection
Transactions
U.S. Patent Prosecution

WIPR Leaders 2023

Sabing has received multiple awards for his legal accomplishments:

  • Recognized as one of the Top Intellectual Property Lawyers in California for 2025 by Daily Journal.
  • Recognized for outstanding work in patent law in the 2024 edition of the Intellectual Asset Management (IAM)Patent 1000 Guide” for Prosecution (2024)
  • Recognized as a Patent Star in Managing IP’s “IP STARS” guide for his outstanding intellectual property legal work in 2018-2024.
  • Recognized by The Legal 500 “United States” for “Leading Lawyers” in Patent Prosecution and Patents: Licensing (2024)
  • Recognized as a “World IP Leader” by World Intellectual Property Review (WIPR) (2023 – 2024)
  • Named one of “The World’s Leading Patent Professionals” for Prosecution in the Patent 1000 guide by Intellectual Asset Management (IAM) magazine (2023). In the 2023 guide, Sabing was described as “an adroit strategist with deep technical understanding,” and as someone who “dispenses the most accurate and pragmatic advice to help clients meet their business goals.”
  • Recognized by The Legal 500 “United States” for Patent Prosecution (2022) and Patent Licensing (2023). He was identified as a Leading Lawyer for Patent Prosecution in 2023.
  • Received “Star” recognition in the “Life Sciences Survey” published by Legal Media Group (LMG) Life Sciences from 2012-2019 and 2022-2024. He was noted as being among the top patent strategists in the country for his patent prosecution, patent advisory, strategy and management practice. Sabing was further recognized for his work with tissue and tissue products, home health and consumer devices, surgery and life support devices, dental devices, general hospital devices and supplies, cosmetic devices, implants and prosthetics, orthopedic devices, respiratory devices, neurovascular devices and cardiovascular devices. In 2018, 2022 and 2024 Sabing was once again named a “Life Science Star” for Patent Prosecution and Patent Strategy & Management.
  • Selected for inclusion in the “Southern California Super Lawyers” list for his work in intellectual property law from 2013-2018 by Super Lawyers magazine.
  • Recognized as one of Southern California’s “Rising Stars” in intellectual property law in a survey of his peers from 2004-2012, published in Los Angeles magazine and Super Lawyers magazine. He was also named one of “OC’s Top Attorneys” in the 2009, 2010, 2011, 2012 and 2013 editions of OC Metro Magazine.
  • Named to the Daily Journal’s list of the “Top Intellectual Property Attorneys of 2014”, where he was recognized among the Top 25 Portfolio Managers & Patent Prosecutors of Intellectual Property. The Daily Journal selects attorneys for inclusion on its list based on a number of criteria, including hundreds of nominations and staff selections, along with each nominee’s major intellectual property successes over the last year.
  • Octane – Board of Directors (August 2015 – Present)
  • American Intellectual Property Law Association (AIPLA)
  • International Association for the Protection of Intellectual Property (AIPPI)
  • Orange County Bar Association
Sabing Lee Headshot

Sabing Lee

Sabing H. Lee's practice includes strategic patent procurement, patent portfolio management, intellectual property due diligence and general counseling on infringement, licensing, international IP protection and post-grant proceedings. Sabing currently represents clients in a wide range of technologies, with an emphasis on medical devices and procedures and materials science.

In the medical device field, Sabing has worked extensively with cardiovascular, orthopedic, wound care and aesthetic technologies. He has been involved in the intellectual property strategy and acquisitions of PercuSurge, Inc. (acquired by Medtronic, Inc.), Flex-Foot, Inc. (acquired by Össur hf.), Endius, Inc. (acquired by Zimmer Holdings, Inc.), ev3 Inc. (acquired by Covidien), IDev Technologies, Inc. (acquired by Abbott), and Tornier NV (merged with Wright Medical Group, Inc.), and CardiAQ Valve Technologies, Inc. (acquired by Edwards Lifesciences Corporation).

Sabing currently serves on the Board of Directors for OCTANe, an organization that drives technology industry growth and innovation in Orange County by connecting ideas and people with resources and capital.

From 2013-2017, Sabing has been recognized as a Southern California Super Lawyer in Intellectual Property by Super Lawyers magazine. He received Star recognition in the 2012, 2013, 2014, 2015 and 2016 editions of LMG Life Sciences, published by Managing Intellectual Property. Sabing was named to the Daily Journal's list of the Top Intellectual Property Attorneys of 2014, where he was recognized among the Top 25 Portfolio Managers & Patent Prosecutors of Intellectual Property. His accomplishments are detailed in the Awards & Honors section.

Sabing joined the firm in 1997 and became a partner in 2003.

View all posts published by Sabing Lee
By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.
close modal